OncoMatch/Clinical Trials/NCT07373782
Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer
Is NCT07373782 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2/3 trial studies Continuous Positive Airway Pressure (CPAP) for breast cancer early stage breast cancer (stage 1-3).
Treatment: Continuous Positive Airway Pressure (CPAP) — This study is a prospective, non-randomized clinical study aimed at investigating the potential benefits of continuous positive airway pressure (CPAP) support during radiotherapy for breast cancer. CPAP is a device commonly used to support breathing, for example in patients with sleep apnea. The investigators expect a reduction in radiation doses to the heart and/or lungs with CPAP-supported radiotherapy compared to standard radiotherapy (without CPAP), which may also lead to a decrease in radiation-induced heart and/or lung conditions in the long term. The study will also examine how the use of a CPAP device can be implemented in daily radiotherapy practice.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Breast Carcinoma
Disease stage
Required: Stage I, II, III
Demographics
Prior therapy
Must have received: breast conserving surgery
Patients that underwent breast conserving surgery (BCS)
Cannot have received: mastectomy
Patients that underwent mastectomy
Cannot have received: radiation therapy
Exception: previous RT with overlapping RT fields with actual target volume
Previous RT with overlapping RT fields with actual target volume
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07373782 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior mastectomy, radiation therapy disqualifies patients from enrollment.
What disease stage is eligible?
Stage I or II or III is required.
Is there an age limit?
Yes. Patients must be 80 years or younger and at least 40 years old.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages